Impact of HLA on the Underlying Primary Diseases in Turkish Patients with End-Stage Renal Disease

Karahan G. E., Seyhun Y., Oguz F. S., Kekik Ç., Onal A. E., Yazici H., ...Daha Fazla

RENAL FAILURE, cilt.31, sa.1, ss.44-49, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 1
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1080/08860220802546297
  • Dergi Adı: RENAL FAILURE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.44-49
  • Anahtar Kelimeler: end-stage renal disease, HLA, disease-association, primary diseases, UNITED-STATES, C ALLELES, TRANSPLANTATION, POPULATIONS, AMYLOIDOSIS, HAPLOTYPES, SURVIVAL
  • İstanbul Üniversitesi Adresli: Evet

Özet

The number of patients with end stage renal disease (ESRD) is increasing faster than the number of renal transplantations performed per year worldwide. Of the primary diseases leading to ESRD, diabetic nephropathy is the leading cause. The purpose of the present study is to investigate the association of HLA with the primary diseases leading to ESRD in Turkish patients. A total of 3230 individuals comprising 587 ESRD patients and 2643 healthy controls were enrolled into the study. Class I HLA-A, -B typing was performed by CDC method, while class II HLA-DRB1 typing was performed by low resolution PCR-SSP. We found a significant negative association between almost all A locus antigens and primary disease groups classified as chronic glomerulonephritis and hypertensive nephrosclerosis (p 0.05). HLA-B58 and HLA-DRB1*03 significantly correlated with amyloidosis and diabetic nephropathy, respectively. Determination of HLAs as risk factors for primary diseases leading to ESRD might be beneficial in preventing progression to ESRD and recurrence of the primary disease post-transplantation.